About HemoSense
HemoSense is a company based in San Jose (United States) founded in 1997 was acquired by Abbott in November 2007. HemoSense has raised $17.7 million across 2 funding rounds from investors including Tredegar, Abbott Global Point of Care and NEA. HemoSense operates in a competitive market with competitors including Hemosonics, Stasys, Exactus, ClotChip and Atantares, among others.
- Headquarter San Jose, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of HemoSense
HemoSense has successfully raised a total of $17.7M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7 million completed in December 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HemoSense
HemoSense has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Tredegar, Abbott Global Point of Care and NEA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Invests in biotech firms developing life-saving drugs and technologies.
|
Locked | Locked | Locked | |
|
Plastic films and aluminum products are manufactured by Tredegar.
|
Locked | Locked | Locked |
Investor details for HemoSense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HemoSense
Investment portfolio details for HemoSense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HemoSense
Detailed financials for HemoSense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hemosense Comparisons
Peer comparison for HemoSense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HemoSense
HemoSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemosonics, Stasys, Exactus, ClotChip and Atantares, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
IVD for hemostasis characterization
|
|
| Locked | Locked | Locked |
Provider of POC device for analyzing blood clotting disorders and platelet dysfunction
|
|
| Locked | Locked | Locked |
POC diagnostics for fibrinolytic status assessment are developed.
|
|
| Locked | Locked | Locked |
Portable tests for blood coagulation analysis are developed.
|
|
| Locked | Locked | Locked |
Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies
|
Detailed competitors of HemoSense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hemosense
Complete news archive for HemoSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HemoSense
HemoSense was founded in 1997 and raised its 1st funding round 3 years after it was founded.
HemoSense is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
HemoSense is a funded company, having raised a total of $17.7M across 2 funding rounds to date.
HemoSense was founded in 1997 in San Jose, United States, and focused on the medical device sector. Development, manufacturing, and marketing of handheld systems for monitoring blood coagulation in warfarin patients were conducted. The INRatio System was provided to measure clotting time at the point of care. Acquisition by Alere Diagnostics occurred in 2013.
HemoSense's top competitors include Hemosonics, Perosphere Technologies and Atantares.
HemoSense has 4 investors. Key investors include Tredegar, Abbott Global Point of Care, NEA, and Turmeric Acquisition Corp.